NCT01331434View on ClinicalTrials.gov

Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

exemestane

25 mg tablet

Trial Locations (1)

65802

Bio-Kinetic Clinical Applications, Inc., Springfield

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01331434 - Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions | Biotech Hunter | Biotech Hunter